Problem.

Prostate cancer is the second most common cancer in men.

In Europe, around 1 million prostate biopsies are carried out each year. Biopsy is still affected by diagnostic errors between 30% and 50%. The main sources of error are target detection and needle insertion: both operator dependent!

Solution.

A safe, accurate and repeatable robot-assisted procedure.

Improve the clinical outcome in needle based prostate biopsy procedures by using AI and robotics through target identification and planning, needle position and biopsy execution.